Latest Bisoprolol Stories
A new study has found that, contrary to current thinking, taking beta blockers that treat high blood pressure does not decrease a person's risk of developing colorectal cancer.
A comparison of several international clinical trials of beta-blocker drugs has shown there are notable differences in how well the drugs prevent deaths in heart failure patients, based on where the patients were treated.
Future studies using universal methods may give physicians clear answers about who should get beta blockers and at what dosage.
In a new study, researchers report that a class of heart medications called beta-blockers can have a helpful, or harmful, effect on the heart, depending on their molecular activity.
Study highlights: -- Although many studies have shown that beta blockers improve outcomes for heart failure patients, the optimum dose is still unknown. -- A new Japanese study finds the smallest dose of beta blockers is as effective as larger ones, with fewer side effects. ORLANDO, Fla., Nov.
Results and updates from eight studies were presented during a late-breaking trials session at Heart Failure 2009.
Beta-blockers heal the heart via the brain when administered during heart failure, according to a new study by UCL (University College London).